These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 31398826)

  • 21. Modeling Brain Disorders Using Induced Pluripotent Stem Cells.
    Vadodaria KC; Jones JR; Linker S; Gage FH
    Cold Spring Harb Perspect Biol; 2020 Jun; 12(6):. PubMed ID: 31767646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid and efficient induction of functional astrocytes from human pluripotent stem cells.
    Canals I; Ginisty A; Quist E; Timmerman R; Fritze J; Miskinyte G; Monni E; Hansen MG; Hidalgo I; Bryder D; Bengzon J; Ahlenius H
    Nat Methods; 2018 Sep; 15(9):693-696. PubMed ID: 30127505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induced pluripotent stem cells (iPSCs) and neurological disease modeling: progress and promises.
    Marchetto MC; Brennand KJ; Boyer LF; Gage FH
    Hum Mol Genet; 2011 Oct; 20(R2):R109-15. PubMed ID: 21828073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of human iPSC-derived astrocytes with potential for disease modeling and drug discovery.
    Soubannier V; Maussion G; Chaineau M; Sigutova V; Rouleau G; Durcan TM; Stifani S
    Neurosci Lett; 2020 Jul; 731():135028. PubMed ID: 32380146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. When glia meet induced pluripotent stem cells (iPSCs).
    Li L; Shi Y
    Mol Cell Neurosci; 2020 Dec; 109():103565. PubMed ID: 33068719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specification of neuronal and glial subtypes from human pluripotent stem cells.
    Liu H; Zhang SC
    Cell Mol Life Sci; 2011 Dec; 68(24):3995-4008. PubMed ID: 21786144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient-Specific iPSC-Derived Astrocytes Contribute to Non-Cell-Autonomous Neurodegeneration in Parkinson's Disease.
    di Domenico A; Carola G; Calatayud C; Pons-Espinal M; Muñoz JP; Richaud-Patin Y; Fernandez-Carasa I; Gut M; Faella A; Parameswaran J; Soriano J; Ferrer I; Tolosa E; Zorzano A; Cuervo AM; Raya A; Consiglio A
    Stem Cell Reports; 2019 Feb; 12(2):213-229. PubMed ID: 30639209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human pluripotent stem cell-derived radial glia recapitulate developmental events and provide real-time access to cortical neurons and astrocytes.
    Duan L; Peng CY; Pan L; Kessler JA
    Stem Cells Transl Med; 2015 May; 4(5):437-47. PubMed ID: 25834120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pluripotent stem cell for modeling neurological diseases.
    Yung JS; Tam PK; Ngan ES
    Exp Cell Res; 2013 Jan; 319(2):177-84. PubMed ID: 23159386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation of Human CD49f
    Barbar L; Rusielewicz T; Zimmer M; Kalpana K; Fossati V
    STAR Protoc; 2020 Dec; 1(3):100172. PubMed ID: 33377066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic and immune dysfunction of glia in neurodegenerative disorders: Focus on iPSC models.
    Rõlova T; Lehtonen Š; Goldsteins G; Kettunen P; Koistinaho J
    Stem Cells; 2021 Mar; 39(3):256-265. PubMed ID: 33270954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of pluripotent stem cell for personalized cell therapies against neurological disorders.
    Ha HY; Jang SH; Jung JW
    J Biomed Biotechnol; 2011; 2011():520816. PubMed ID: 22203784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In-a-dish: induced pluripotent stem cells as a novel model for human diseases.
    Beltrão-Braga PC; Pignatari GC; Russo FB; Fernandes IR; Muotri AR
    Cytometry A; 2013 Jan; 83(1):11-7. PubMed ID: 23281003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human iPSC-derived glia models for the study of neuroinflammation.
    Stöberl N; Maguire E; Salis E; Shaw B; Hall-Roberts H
    J Neuroinflammation; 2023 Oct; 20(1):231. PubMed ID: 37817184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human stem cell-derived astrocytes and their application to studying Nrf2-mediated neuroprotective pathways and therapeutics in neurodegeneration.
    Gupta K; Chandran S; Hardingham GE
    Br J Clin Pharmacol; 2013 Apr; 75(4):907-18. PubMed ID: 23126226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modeling Neurodevelopmental and Neuropsychiatric Diseases with Astrocytes Derived from Human-Induced Pluripotent Stem Cells.
    Ren B; Dunaevsky A
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene profiling of human induced pluripotent stem cell-derived astrocyte progenitors following spinal cord engraftment.
    Haidet-Phillips AM; Roybon L; Gross SK; Tuteja A; Donnelly CJ; Richard JP; Ko M; Sherman A; Eggan K; Henderson CE; Maragakis NJ
    Stem Cells Transl Med; 2014 May; 3(5):575-85. PubMed ID: 24604284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SSEA4-positive pig induced pluripotent stem cells are primed for differentiation into neural cells.
    Yang JY; Mumaw JL; Liu Y; Stice SL; West FD
    Cell Transplant; 2013; 22(6):945-59. PubMed ID: 23043799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing.
    Pistollato F; Canovas-Jorda D; Zagoura D; Price A
    J Vis Exp; 2017 Jun; (124):. PubMed ID: 28654077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.